FDA Approved Synergy Ablation System as Treatment for AF
The FDA has decided to approve the Synergy Ablation System, which is made by ActriCure. It is to be used as a treatment of atrial fibrillation (AF) in patients who...
FDA Issues Stricter Restrictions on Multaq
The FDA has decided to use some more restrictions on the approved use of the atrial fibrillation (AF) drug Multaq after studies have shown the drug can double a patient’s...
Study: Cox-2 Inhibitors Decrease CV Risks, but Increase AF Risks
According to a new cohort study of Cox-2 inhibitors, the drugs do not pose an increased risk of patients suffering from MI, strokes or heart failures. The study was conducted...
Study: AF Patients Taking Vitamins More Likely to Take Other Meds Improperly
A new study has found that patients who have heart conditions like atrial fibrillation (AF) and take vitamins are more likely to take their other medications the wrong way. This...
Catheter Ablation Better than Drugs for Paroxysmal AF
New research is showing that catheter ablation treatments work as well as or better than drugs at helping to reduce occasional episodes of irregular heartbeats in patients suffering from atrial...